PUYI Biotech has completed a 150 million yuan Series B financing round.

On March 16, Putrans Biotechnology Co., Ltd. officially announced the completion of a 150 million RMB Series B financing. This round of financing was led by Zhejiang Galaxy Guoke Consumer Health Equity Investment Fund, with participation from Guoke Chuanghui Investment, China Bank Capital, and Chang Development Group. Existing shareholders Wan Fu Biotechnology and IDG Capital continued to increase their investments.